161 related articles for article (PubMed ID: 36826081)
1. A Retrospective Study of Renal Growth Changes after Proton Beam Therapy for Pediatric Malignant Tumor.
Li Y; Mizumoto M; Oshiro Y; Nitta H; Saito T; Iizumi T; Kawano C; Yamaki Y; Fukushima H; Hosaka S; Maruo K; Kamizawa S; Sakurai H
Curr Oncol; 2023 Jan; 30(2):1560-1570. PubMed ID: 36826081
[TBL] [Abstract][Full Text] [Related]
2. Late Changes in Renal Volume and Function after Proton Beam Therapy in Pediatric and Adult Patients: Children Show Significant Renal Atrophy but Deterioration of Renal Function Is Minimal in the Long-Term in Both Groups.
Li Y; Mizumoto M; Nitta H; Fukushima H; Suzuki R; Hosaka S; Yamaki Y; Murakami M; Baba K; Nakamura M; Ishida T; Makishima H; Iizumi T; Saito T; Numajiri H; Nakai K; Kamizawa S; Kawano C; Oshiro Y; Sakurai H
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730586
[TBL] [Abstract][Full Text] [Related]
3. An analysis of muscle growth after proton beam therapy for pediatric cancer.
Nitta H; Mizumoto M; Li Y; Oshiro Y; Fukushima H; Suzuki R; Hosaka S; Saito T; Numajiri H; Kawano C; Kamizawa S; Maruo K; Sakurai H
J Radiat Res; 2024 Mar; 65(2):251-255. PubMed ID: 38265112
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after proton beam therapy for pediatric tumors: a Japanese national survey.
Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
Cancer Sci; 2017 Mar; 108(3):444-447. PubMed ID: 28004469
[TBL] [Abstract][Full Text] [Related]
5. Regression and pseudoprogression of pediatric optic pathway glioma in patients treated with proton beam therapy.
Youn SH; Kim H; Lee SH; Kim JY
Pediatr Blood Cancer; 2022 Mar; 69(3):e29434. PubMed ID: 34766717
[TBL] [Abstract][Full Text] [Related]
6. Radiation-Induced Cerebral Microbleeds in Pediatric Patients With Brain Tumors Treated With Proton Radiation Therapy.
Kralik SF; Mereniuk TR; Grignon L; Shih CS; Ho CY; Finke W; Coleman PW; Watson GA; Buchsbaum JC
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1465-1471. PubMed ID: 30092336
[TBL] [Abstract][Full Text] [Related]
7. Can We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation.
Jouglar E; Wagner A; Delpon G; Campion L; Meingan P; Bernier V; Demoor-Goldschmidt C; Mahé MA; Lacornerie T; Supiot S
PLoS One; 2016; 11(10):e0164643. PubMed ID: 27764132
[TBL] [Abstract][Full Text] [Related]
8. Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.
Riechardt AI; Karle B; Cordini D; Heufelder J; Budach V; Joussen AM; Gollrad J
Strahlenther Onkol; 2017 Nov; 193(11):943-950. PubMed ID: 28631017
[TBL] [Abstract][Full Text] [Related]
9. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
[TBL] [Abstract][Full Text] [Related]
10. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.
Parzen JS; Hartsell W; Chang J; Apisarnthanarax S; Molitoris J; Durci M; Tsai H; Urbanic J; Ashman J; Vargas C; Stevens C; Kabolizadeh P
Radiat Oncol; 2020 Nov; 15(1):255. PubMed ID: 33148296
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
[TBL] [Abstract][Full Text] [Related]
13. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
[TBL] [Abstract][Full Text] [Related]
14. Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan.
Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
Cancer Med; 2016 Jul; 5(7):1519-25. PubMed ID: 27165972
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea.
Kim TW; Choi E; Park J; Shin DH; Jung SK; Seok S; Cho KH; Kim JY; Kim DY; Kim TH; Suh YK; Kim YJ; Moon SH
Cancer Res Treat; 2018 Apr; 50(2):335-344. PubMed ID: 28421723
[TBL] [Abstract][Full Text] [Related]
16. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
[TBL] [Abstract][Full Text] [Related]
17. Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide.
Mizumoto M; Yamamoto T; Ishikawa E; Matsuda M; Takano S; Ishikawa H; Okumura T; Sakurai H; Matsumura A; Tsuboi K
J Neurooncol; 2016 Oct; 130(1):165-170. PubMed ID: 27535747
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of neuroimaging findings post-proton beam therapy in a large pediatric cohort.
Bhattacharya D; Chhabda S; Lakshmanan R; Tan R; Warne R; Benenati M; Michalski A; Aquilina K; Jacques T; Hargrave D; Chang YC; Gains J; Mankad K
Childs Nerv Syst; 2021 Feb; 37(2):435-446. PubMed ID: 32705327
[TBL] [Abstract][Full Text] [Related]
20. Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas.
Fuji H; Schneider U; Ishida Y; Konno M; Yamashita H; Kase Y; Murayama S; Onoe T; Ogawa H; Harada H; Asakura H; Nishimura T
Radiat Oncol; 2013 Nov; 8():255. PubMed ID: 24180282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
